UBX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (15 Apr 2024 @ 16:00):

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging...

Stats
Today's Volume	33 331.00
Average Volume	91 127.00
Market Cap	25.18M
EPS	$0 ( 2024-04-03 )
Next earnings date	( $-0.720 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.470
ATR14	$0.00700 (0.47%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-26	Nguyen Alexander Hieu	Buy	30 000	Stock Option (Right to Buy)
2024-03-26	Nguyen Alexander Hieu	Buy	20 000	Common Stock, $0.0001 par value
2024-02-02	Ghosh Anirvan	Sell	680	Common Stock, $0.0001 par value
2024-01-30	Ghosh Anirvan	Sell	1 183	Common Stock, $0.0001 par value
2023-11-02	Ghosh Anirvan	Sell	589	Common Stock, $0.0001 par value

INSIDER POWER
55.32
Last 99 transactions
Buy: 2 792 498 \| Sell: 401 244

Volume Correlation

Long: 0.03 (neutral)

Short: -0.54 (weak negative)

Signal:(44.599) Neutral

UNITY Biotechnology Inc Correlation

10 Most Positive Correlations
XLRN	0.938
BRACU	0.938
NVCN	0.934
LX	0.931
ATRS	0.924
SY	0.924
ATCX	0.923
PUCK	0.919
GXII	0.919
OVID	0.918

10 Most Negative Correlations
NAKD	-0.928
AHPI	-0.923
AMGN	-0.908
PROC	-0.906
GRPH	-0.905
GRIN	-0.903
LCAP	-0.899
LAWS	-0.896
TRIT	-0.892
CYTO	-0.888

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

UNITY Biotechnology Inc Correlation - Currency/Commodity

0.05
( neutral )

0.07
( neutral )

0.00
( neutral )

-0.04
( neutral )

UNITY Biotechnology Inc Financials

Annual	2022
Revenue:	$236 000
Gross Profit:	$-1.94M (-823.73 %)
EPS:	$-6.08

Q3	2023
Revenue:	$0
Gross Profit:	$-308 000 (0.00 %)
EPS:	$-1.050

Q2	2023
Revenue:	$0
Gross Profit:	$-314 000 (0.00 %)
EPS:	$-0.850

Q1	2023
Revenue:	$0
Gross Profit:	$-329 000 (0.00 %)
EPS:	$-0.840

Financial Reports:

No articles found.

UNITY Biotechnology Inc

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.